Cytokinetics Financial Overview
Cytokinetics's market cap is currently $7.67B. The company's EPS TTM is $-2.55; its P/E ratio is -10.40; Cytokinetics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-1.55. See an overview of income statement, balance sheet, and cash flow financials.
